PDX Select
Model Bank
Search through our extensive and highly characterized PDX bank.
1393 models
page 38 of 59
CTG-2697
Breast
Adenocarcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Breast
Disease stage
III
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2699
Acute myeloid leukemia (AML)
Treatment history
Naive
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2700
Acute myeloid leukemia (AML)
Treatment history
Pretreated
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2702
Acute myeloid leukemia (AML)
Treatment history
Pretreated
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2704
Acute myeloid leukemia (AML)
Treatment history
Naive
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2708
NSCLC
Adenocarcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Lung
Disease stage
I
Lumin data
RNA-Seq, WES
View model →
CTG-2712
Colorectal
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Naive
Harvest site
Liver
Disease stage
Not Available
Lumin data
RNA-Seq, WES
View model →
CTG-2713
Glioblastoma multiforme (GBM)
Not available
Tumor status
Primary
Treatment history
Naive
Harvest site
Brain
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2715
Head and neck
Carcinoma
Tumor status
Local metastatic
Treatment history
Pretreated
Harvest site
Neck
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2716
Lymphoma
Germinal center
Tumor status
Primary
Treatment history
Naive
Harvest site
Ileum
Disease stage
Not Available
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2718
Head and neck
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Tongue
Disease stage
III
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2719
Head and neck
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Oral Cavity
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2721
Breast
Invasive ductal carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Liver
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2722
Sarcoma
Pleomorphic
Tumor status
Metastatic
Treatment history
Naive
Harvest site
Liver
Disease stage
Not Available
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2723
Head and neck
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Tongue
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2733
Ovarian
Carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Groin
Disease stage
III
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2734
Melanoma
Pending
Tumor status
Metastatic
Treatment history
Naive
Harvest site
Abdomen
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2735
Sarcoma
Spindle cell
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Shoulder
Disease stage
Not Available
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2737
Endometrial
Endometrioid carcinoma
Tumor status
Local metastatic
Treatment history
Pretreated
Harvest site
Abdomen
Disease stage
III
Lumin data
RNA-Seq, WES
View model →
CTG-2739
Head and neck
Squamous cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Tongue
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2740
Cholangiocarcinoma
Adenocarcinoma
Tumor status
Metastatic
Treatment history
Naive
Harvest site
Liver
Disease stage
Not Available
Lumin data
RNA-Seq, WES
View model →
CTG-2741
Head and neck
Squamous carcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Buccal
Disease stage
IV
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2742
Breast
Invasive ductal carcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Breast
Disease stage
III
Lumin data
RNA-Seq, WES, Proteomics
View model →
CTG-2745
Breast
Ductal adenocarcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Breast
Disease stage
III
Lumin data
RNA-Seq, WES, Proteomics
View model →
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.